Altimmune (ALT) Return on Sales (2010 - 2025)
Altimmune's (ALT) quarterly Return on Sales came in at 29.18% in Q4 2025, up 7554.0% year-on-year from 0.38% in Q4 2024, and up 176.72% on a QoQ basis from 38.03% in Q3 2025.
Altimmune (ALT) Return on Sales (2010 - 2025) Analysis & Trends
Altimmune (ALT) has 16 years of Return on Sales data on file, last reported at 29.18% in Q4 2025.
- On a quarterly basis, Return on Sales rose 7554.0% year-over-year to 29.18% in Q4 2025; TTM through Dec 2025 was 3.69%, a 5122.0% increase from a year earlier, with the FY2025 full-year figure at 3.69%, up 4124.0% from the prior year.
- Return on Sales for Q4 2025 stood at 29.18%, up from 38.03% in the prior quarter.
- Over the last five years, Return on Sales for ALT reached as high as 29.18% in Q4 2025 and fell as low as 117.58% in Q3 2022.
- Historically, Return on Sales has averaged 24.3% across 5 years, with a median of 17.39% in 2022.
- Across the five-year window, Return on Sales plunged 11546 bps in 2022 and surged 11701 bps in 2023, its largest moves.
- Year by year, Return on Sales stood at 0.02% in 2021, then slumped by 22485 bps to 3.71% in 2022, then tumbled by 131 bps to 8.55% in 2023, then tumbled by 442 bps to 46.36% in 2024, then soared by 163 bps to 29.18% in 2025.
- Per Business Quant data, the three most recent Return on Sales figures were 29.18% in Q4 2025, 38.03% in Q3 2025, and 44.29% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.18% |
| Sep 30, 2025 | -38.03% |
| Jun 30, 2025 | -44.29% |
| Mar 31, 2025 | -39.15% |
| Dec 31, 2024 | -46.36% |
| Sep 30, 2024 | -45.69% |
| Jun 30, 2024 | -49.28% |
| Mar 31, 2024 | -48.79% |
| Dec 31, 2023 | -8.55% |
| Sep 30, 2023 | -0.57% |
| Jun 30, 2023 | -28.16% |
| Mar 31, 2023 | -9.61% |
| Dec 31, 2022 | -3.71% |
| Sep 30, 2022 | -117.58% |
| Jun 30, 2022 | -25.17% |
| Mar 31, 2022 | -6.12% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -2.12% |
| Jun 30, 2021 | -1.81% |
| Mar 31, 2021 | -0.18% |